In addition, the expression of cancer stemness markers such as CD24, CD44, and CD133 has been linked to decreased survival in PC. For example, CD24 is overexpressed in high-grade tumors and more advanced PC stages, and lymphatic invasion and venous invasion are observed more frequently in the CD24 + PC, suggesting its role in the progression of PC [188]. This evidence concerns the gene CD44 and cancer.